BiotechTube
Home/Investors/Institut Mérieux (majority shareholder)

Institut Mérieux (majority shareholder)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$10.9B
Focus Areas
6
Top Stage
Commercial

Investment Focus

Infectious DiseasesMicrobiologySepsisAntimicrobial ResistancePoint-of-Care TestingOncology

Portfolio Companies

CompanyValuation
bioMerieux$10.7B
Transgene SA$204.9M

Frequent Co-Investors

Public shareholders1 sharedPublic market investors1 sharedBpifrance1 shared